WG
Insider
William Guyer
Chief Development OfficerWilliam Guyer (Chief Development Officer) filed 15 Form 4 reports in the trailing twelve months (0 purchases, 15 sales, 1 filed past the two-business-day deadline), most often in Corcept Therapeutics Incorporated (CORT). The largest single filing was $1.8M of CORT (16,300 sh across 2 lots, as filed), executed Aug 10.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
15
0 buys · 15 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$15.1M
shares × price, as filed
Last traded
Aug 10
Filed Aug 12
Median ADV $130.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $25.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
15 filings
Sector per market data · by filing · past 12 months
Most traded names
CORTRecent filings
CORTSALE
Corcept Therapeutics Incorporated
View filing →
$1.8M16,300 sh across 2 lots
Exec Aug 10
Filed Aug 12 · 4:26 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $419K
3,700 sh × $113.12
Exec Aug 4
Filed Aug 6 · 6:44 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $1.8M
19,048 sh × $93.11
Exec Jul 7
Filed Jul 8 · 7:54 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $1.4M
20,000 sh × $70.60
Exec Jun 2
Filed Jun 4 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $1.0M
20,000 sh × $51.83
Exec May 5
Filed May 7 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $819K
20,000 sh × $40.97
Exec Apr 7
Filed Apr 8 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $424K
11,767 sh × $36.01
Exec Mar 20
Filed Mar 24 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $296K
8,233 sh × $35.99
Exec Mar 4
Filed Mar 6 · 5:30 PM ET More filings →